OFFICIAL PUBLICATION OF

by its subsidiary APPco

No new Ozempic scripts: TGA

Nicholas O’Donoghue 22/09/2023

Prescribers urged not to start new patients on Ozempic, as Novo Nordisk warns of supply shortages throughout 2024 Ozempic supplier, Novo Nordisk, is warning that supply of the diabetes medication will be limited for the rest of this year and throughout 2024, due to accelerated demand in recent months. In response to the supply

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

No new Ozempic scripts: TGA

Previous Private label to drive retail growth: Sigma

Next Immune health: the impact of Covid

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Private label to drive retail growth: Sigma

Next Immune health: the impact of Covid

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.